Community/Retail

Multiple sclerosis patients who used a balance board accessory for a video game console saw changes in brain connections and improved their balance.

Experimental vaccine could begin clinical trials in humans in early 2015.

PARADIGM-HF study results offer insight into a new heart failure treatment mechanism, neprilysin inhibition.

Children and adolescents who received antipsychotic medications had an increased absolute risk of developing type 2 diabetes.

Pharmacists can benefit from taking time out to assess the hectic pace of their professional lives.

Wine consumption is cardioprotective, but only in patients who exercise, according to a new study.

Director of Centers for Disease Control and Prevention cautions that outbreak in West Africa is outpacing the response.

Following recent analysis, researchers found that infants who received HIV vaccines showed immune response to the vaccine.

The NCPA recently wrote to the U.S. House of Representatives and encouraged them to pass a bill that would make great strides in reducing the number of Americans misusing prescription drugs. Suncoast Rehab backs the NCPA in their efforts, and says that communities must take it one step further in fighting this epidemic.

An analysis of data from 48 trials found little difference in total weight loss between several diet programs.

Vaccine targets the diarrhea-causing bacterium linked to 14,000 US deaths annually.

Need a break? Check out our selection of entertaining science news stories.

National Institutes of Health and GlaxoSmithKline will conduct safety evaluations on collaborative treatment in human subjects starting this week.

New anti-superbug gel can penetrate the protective coating that makes certain bacteria resistant to traditional therapies.

Adolescents exposed to gestational diabetes in utero have a higher risk of developing impaired glucose tolerance.

Researchers seek to get ahead of potential future Ebola outbreaks.

Self-monitoring is an effective method for hypertensive patients who are at risk for cardiovascular comorbidity.

TIM-family proteins may be able to block a wide range of viral infections.